Skip to content

Clinical Reporting to Alleviate the Nocebo Effect

Clinical Reporting to Alleviate the Nocebo Effect (CRANE)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06103474
Acronym
CRANE
Enrollment
18
Registered
2023-10-26
Start date
2024-01-14
Completion date
2025-11-11
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nocebo Effect

Brief summary

Terminology in radiology reports may cause patients harm by anchoring to or justifying a particular diagnosis. This phenomenon is known as the nocebo effect. MRI may cause patients to pursue more invasive procedures with little added benefit. This study aims to reproduce a study to determine the impact of clinical reporting on patient care and outcomes for those suffering from lower back pain.

Interventions

DIAGNOSTIC_TESTLumbar Magnetic Resonance Imaging (MRI)

Lumbar Magnetic Resonance Imaging (MRI)

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
American Roentgen Ray Society
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Masking description

Interpreting radiologists will be blinded to survey data. The PI will be blinded to the intervention type during the review.

Intervention model description

Survey, cross-sectional study of sixty (n=60) participants undergoing MRI for lower back pain will be randomized to receive an anatomic report (standard of care) versus a Clinical Report (CR). Ordering physicians receiving the Clinical Reports will be instructed to avoid terms that may result in cyberchondria or fear (e.g. disc bulge or nerve impingement) when discussing MRI results.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* History of lower back pain undergoing MRI * Greater than 18 years of age * Able to understand and willing to comply with all study procedures and is available for the duration of the study

Exclusion criteria

* A potential subject who meets any of the following criteria will be excluded from participation in the study: * Acute lower back pain secondary to trauma within 1 months * Severe cord compression on MRI * Cord signal abnormality on MRI * Metastatic cancer * Spinal epidural abscess * Vertebral osteomyelitis * Judgement of the ordering physician (e.g. focal neurologic deficit) * Anything that, in the opinion of the investigator or team, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study

Design outcomes

Primary

MeasureTime frame
Improvement of the visual analog scale (VAS) pain score in Clinical Report Cohort.6 weeks post intervention

Secondary

MeasureTime frame
Improvement in pain interference measured via brief pain inventory6 weeks post intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026